“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
The pharmaceutical industry faces unsustainable program failure despite significant increases in investment. Dwindling discovery pipelines, rapidly expanding R&D budgets and increasing regulatory control, predict significant gaps in the future drug markets. The cumulative duration of discovery f...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2016-09-01
|
| Col·lecció: | Proteomes |
| Matèries: | |
| Accés en línia: | http://www.mdpi.com/2227-7382/4/3/28 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|